Endocrine News and Research

RSS

Study discovers health care gap in treating young patients with thyroid cancer

Thyroid cancer is the third most common malignancy in children, and the incidence is rising approximately one percent per year. Now a new analysis published in the October issue of Annals of Surgical Oncology indicates that although the proportion of young patients undergoing total thyroidectomy increased by 34 percent between 1985 and 2007, a variety of hospital and patient factors—including disparities in access to surgeons and state-of-the-art care—affect whether a child actually receives this procedure or another less extensive operation.

16 Nov 2010

Popular antimicrobial chemicals may not be safe for human health and environment

Killing microorganisms has become a national obsession. A pair of antimicrobial compounds known as triclosan and triclocarban are lately the weapons of choice in our war of attrition against the microbial world. Both chemicals are found in an array of personal care products like antimicrobial soaps, and triclosan also is formulated into everyday items ranging from plastics and toys to articles of clothing.

10 Nov 2010

Using mild painkillers during pregnancy can increase risk of male reproductive disorders

New evidence has emerged that the use of mild painkillers such as paracetamol, aspirin and ibuprofen, may be part of the reason for the increase in male reproductive disorders in recent decades.

10 Nov 2010

Testosterone treatment for frailty in older men lacks long term benefits

The beneficial effects of six months of testosterone treatment on muscle mass, strength and quality of life in frail elderly men are not maintained at six months post-treatment, according to a study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

4 Nov 2010

Novel serum test may help diagnose early pregnancy location and outcome

Researchers may have identified a promising novel diagnostic biomarker for ectopic pregnancy, according to a study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). In the western world, deaths from ectopic pregnancy are not common but in the developing world one in ten women who are admitted with an ectopic pregnancy die.

4 Nov 2010

Bolder BioTechnology receives $1.2 million in Qualifying Therapeutic Discovery Project Grants

Bolder BioTechnology, Inc. today announced that it has been awarded a total of $1.2 million in Qualifying Therapeutic Discovery Project Grants. Grants were awarded for qualified investments under the Qualifying Therapeutic Discovery Project Tax Credit Program, which authorized up to $1 billion in tax credits or grants to biopharmaceutical companies with 250 or fewer employees.

4 Nov 2010

Endocrine Society unveils new guideline on endocrine and nutritional management of post-bariatric surgery patients

The Endocrine Society released a new clinical practice guideline for the nutritional and endocrine management of adults after bariatric surgery, including those with diabetes mellitus. The guideline features a series of evidence-based clinical recommendations developed by an expert task force. The guideline is published in the November 2010 issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society.

4 Nov 2010

Study demonstrates widespread internal exposure of humans to cosmetic UV filters

An investigation conducted in the context of the Swiss National Research Programme (NRP50), Endocrine Disrupters: Relevance to Humans, Animals and Ecosystems, demonstrates for the first time that internal exposure of humans to cosmetic UV filters is widespread.

3 Nov 2010

NPS third quarter net loss increases to $15.7 million

NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today reported its results for the third quarter 2010.

2 Nov 2010

Eli Lilly's new research center to focus on diabetes in China

Eli Lilly and Company announced today plans to open a research center focused on diabetes in China, where the incidence of the disease has reached epidemic proportions.

2 Nov 2010

Merck reports $342 million net income for 2010 third quarter

Merck & Co., Inc. today announced financial results for the third quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the third quarter of $0.85, which excludes purchase accounting adjustments, restructuring costs, merger-related expenses and a $950 million legal reserve.

29 Oct 2010

High urine BPA levels associated with decreased sperm quality

Increasing urine BPA (Bisphenol-A) level was significantly associated with decreased sperm concentration, decreased total sperm count, decreased sperm vitality and decreased sperm motility, according to a Kaiser Permanente study appearing in the journal of Fertility and Sterility.

28 Oct 2010

Endocrine disrupting chemicals may affect human reproductive system: Research

New research has provided the first evidence that 'gender bending' chemicals which find their way from human products into rivers and oceans can have a significant impact on the ability of fish to breed in UK Rivers.

27 Oct 2010

New research center to study effects of BPA, phthalates on children

A new research center based at the University of Illinois will investigate whether regular exposure to bisphenol A and phthalates - chemicals widely used in plastics and other consumer products - can alter infant and adolescent development, cognition or behavior.

22 Oct 2010

Major companies phase out BPA from food and beverage packaging

Major brand name companies including Hain Celestial, H.J. Heinz, ConAgra, and General Mills are taking a leadership role in responding to consumer market shifts as awareness about health hazards of the endocrine disrupting chemical bisphenol A (BPA) in food can linings rises.

21 Oct 2010

Endocrine Society's statement clarifies association between hormone therapy and breast cancer risk

Richard J. Santen, MD, lead author of The Endocrine Society's Scientific Statement on menopausal hormone therapy, can provide clarity on the association of hormone therapy and increased risk of breast cancer as reported in an article published this week in The Journal of the American Medical Association (JAMA)

21 Oct 2010

Study finds adipose dysfunction linked to steatosis, necroinflammation in G1 CHC patients

Researchers at the University of Palermo in Italy provide the evidence that a higher visceral adiposity index score-a new index of adipose dysfunction-has a direct correlation with viral load and is independently associated with both steatosis and necroinflammatory activity in patients with genotype 1 chronic hepatitis C (G1 CHC).

20 Oct 2010

AACE publishes consensus statement for continuous glucose monitoring

The American Association of Clinical Endocrinologists (AACE) today published a consensus statement for continuous glucose monitoring (CGM) online, and the statement will be published in the next issue of the association's official medical journal Endocrine Practice.

14 Oct 2010

Collaboration between different specialties needed to realize potential of Patient Centered Medical Home

In order to realize the full potential of the Patient Centered Medical Home (PCMH) model of patient care to improve coordination and integration, the cooperation of subspecialist physicians and other health care professionals must be ensured, says a new policy paper from the American College of Physicians (ACP).

13 Oct 2010

PlastiPure, ReliaBrand partner to produce EA-Free plastic consumer products

PlastiPure, a safer-plastics technology company, has announced a partnership with ReliaBrand to license infant feeding, sports bottle, food packaging, and medical products free of harmful chemicals that cause estrogenic activity (EA). Chemicals with EA have been strongly linked to adverse health effects such as birth defects, reproductive cancers, and behavioral and learning disorders. The widely known chemicals BPA and phthalates are only a few of thousands of chemicals suspected to have EA.

11 Oct 2010

Endocrine News and Research

Study discovers health care gap in treating young patients with thyroid cancer

Popular antimicrobial chemicals may not be safe for human health and environment

Using mild painkillers during pregnancy can increase risk of male reproductive disorders

Testosterone treatment for frailty in older men lacks long term benefits

Novel serum test may help diagnose early pregnancy location and outcome

Bolder BioTechnology receives $1.2 million in Qualifying Therapeutic Discovery Project Grants

Endocrine Society unveils new guideline on endocrine and nutritional management of post-bariatric surgery patients

Study demonstrates widespread internal exposure of humans to cosmetic UV filters

NPS third quarter net loss increases to $15.7 million

Eli Lilly's new research center to focus on diabetes in China

Merck reports $342 million net income for 2010 third quarter

High urine BPA levels associated with decreased sperm quality

Endocrine disrupting chemicals may affect human reproductive system: Research

New research center to study effects of BPA, phthalates on children

Major companies phase out BPA from food and beverage packaging

Endocrine Society's statement clarifies association between hormone therapy and breast cancer risk

Study finds adipose dysfunction linked to steatosis, necroinflammation in G1 CHC patients

AACE publishes consensus statement for continuous glucose monitoring

Collaboration between different specialties needed to realize potential of Patient Centered Medical Home

PlastiPure, ReliaBrand partner to produce EA-Free plastic consumer products

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News